Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement
Status:
Unknown status
Trial end date:
2020-03-15
Target enrollment:
Participant gender:
Summary
This is a randomized clinical trial, double-blind, placebo-controlled study with the goal to
assess the influence of using N-AcetylCysteyn (NAC) for prevention of AKI (Acute Kidney
Injury) in post operatory of valve replacement until their discharge or death